Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-02

Clinical Trial Update: Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether vitamin D supplementation affects serum BDNF levels and cognitive function in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Schizophrenia | Phase 3 | Status: UNKNOWN